Skip to content

Clinical trials

Observational Carcinoma, Hepatocellular trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Observational Country / region: Germany Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20081
20102
20111
20131
20152
20161
20171
20184
20192
20201
20212
20222
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting5
Terminated3
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer3
University Hospital Freiburg3
Terumo Europe N.V.2
University Hospital Muenster2
University Hospital Tuebingen2
Boston Scientific Corporation1
Cardiovascular and Interventional Radiological Society of Europe1
Charite University, Berlin, Germany1
Eisai Inc.1
Exact Sciences Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular25
Liver Neoplasms5
Liver Cirrhosis4
Cholangiocarcinoma3
Hepatitis C3
Liver Diseases2
Neoplasm Metastasis2
Acquired Immunodeficiency Syndrome1
Cardiovascular Diseases1
Diabetes Mellitus, Type 21

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.